Compare CVS Health Corp (CVS) vs Lumen Technologies Inc (LUMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Lumen Technologies Inc — how do they compare? CVS Health Corp trades at $93.6 (market cap $119.58B), while Lumen Technologies Inc trades at $6.36 (market cap $6.58B). The key difference: CVS Health Corp is far larger — about 18.2× Lumen Technologies Inc's market cap, and CVS Health Corp pays a 2.84% dividend while Lumen Technologies Inc pays none. Which is the better fit depends on your goals.
| CVS | LUMN | |
|---|---|---|
Market Cap | $119.58B | $6.58B |
Sector | Health | Media |
52-Week High | $110.60 | $11.83 |
52-Week Low | $65.51 | $3.95 |
Enterprise Value | $181.93B | $18.20B |
Dividend Yield | 2.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.67, down slightly by 0.03% today. The stock shows strong fundamental momentum with recent quarterly earnings beats, including Q2 2026 EPS of $2.58 versus $1.87 expected, and raised 2026 guidance. Valuation metrics appear reasonable with a P/E of 24.67 and P/S of 0.29. Technical indicators are mixed with a bullish overall signal but bearish moving averages, with key support at $95 and resistance at $96.
The outlook for CVS is positive, supported by earnings strength and analyst consensus, but risks include margin pressure and rising debt levels. The consensus price target of $115.90 implies significant upside, though investors should monitor execution on guidance and healthcare regulatory changes.
LUMN stock trades at $6.64, up 6.41% on the day, with a neutral technical stance. Recent Q2 2026 earnings beat estimates despite a 9.3% revenue decline, as strategic revenues grew 14.1%. The company maintains a high debt load of $17.49 billion, but operating cash flow remains strong at $4.74 billion for 2025. CEO share purchases and board appointments signal internal confidence amid a challenging transformation.
The outlook is cautious; while digital transformation shows progress, persistent revenue declines and negative net income margins pose significant risks. Analyst consensus is a Hold with a $7.67 price target, reflecting skepticism about near-term profitability. High debt and legacy business erosion remain key concerns for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Lumen Technologies Inc
With 450,000 route miles of fiber, including over 35,000 route miles of subsea fiber connecting Europe, Asia, and Latin America, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 further shifted the company's operations toward businesses (over 70% of revenue) and away from its legacy consumer business. Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.
Read more on LUMN →
